Repurposing Anti-TNF for Treating Dupuytren's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 2, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Dupuytren's Disease
Interventions
DRUG

Adalimumab

DRUG

Saline

Trial Locations (3)

9700 RB

The University Medical Centre, Groningen

EH1 3EG

NHS Lothian, Edinburgh

OX3 9DU

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Department of Health, United Kingdom

OTHER_GOV

collaborator

Wellcome Trust

OTHER

collaborator

180 Therapeutics LP

OTHER

lead

University of Oxford

OTHER